Хайлтын үр дүнгүүд - Martin Reck

Үр дүнг сайжруулах
  1. 1
    What future opportunities may immuno-oncology provide for improving the treatment of patients with lung cancer?

    What future opportunities may immuno-oncology provide for improving the treatment of patients with lung cancer? -н Martin Reck

    Хэвлэсэн 2012
    Бүрэн текст авах Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  2. 2
    Implications for Clinical Practice

    Implications for Clinical Practice -н Martin Reck

    Хэвлэсэн 2012
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  3. 3
    First-line treatment of EGFR-mutated nonsmall cell lung cancer: critical review on study methodology

    First-line treatment of EGFR-mutated nonsmall cell lung cancer: critical review on study methodology -н Martin Sebastian, Alexander Schmittel, Martin Reck

    Хэвлэсэн 2014
    Бүрэн текст авах Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  4. 4
    The Future of Immunotherapy in the Treatment of Small Cell Lung Cancer

    The Future of Immunotherapy in the Treatment of Small Cell Lung Cancer -н Leora Horn, Martin Reck, David R. Spigel

    Хэвлэсэн 2016
    Бүрэн текст авах Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  5. 5
    Lactate dehydrogenase as prognostic factor in limited and extensive disease stage small cell lung cancer – A retrospective single institution analysis

    Lactate dehydrogenase as prognostic factor in limited and extensive disease stage small cell lung cancer – A retrospective single institution analysis -н Andreas Hermes, U. Gatzemeier, Benjamin Waschki, Martin Reck

    Хэвлэсэн 2010
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  6. 6
    Nivolumab plus ipilimumab in non-small-cell lung cancer

    Nivolumab plus ipilimumab in non-small-cell lung cancer -н Martin Reck, Hossein Borghaei, Kenneth J. O’Byrne

    Хэвлэсэн 2019
    Бүрэн текст авах Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  7. 7
    Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer

    Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer -н John V. Heymach, David H. Harpole, Martin Reck

    Хэвлэсэн 2024
    Бүрэн текст авах
    Carta
    Жагсаалт руу хадгалах
    -д хадгалсан:
  8. 8
    Addressing CPI resistance in NSCLC: targeting TAM receptors to modulate the tumor microenvironment and future prospects

    Addressing CPI resistance in NSCLC: targeting TAM receptors to modulate the tumor microenvironment and future prospects -н Solange Peters, Luis Paz‐Ares, Roy S. Herbst, Martin Reck

    Хэвлэсэн 2022
    Бүрэн текст авах Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  9. 9
    Targeting KRAS in non-small-cell lung cancer: recent progress and new approaches

    Targeting KRAS in non-small-cell lung cancer: recent progress and new approaches -н Martin Reck, David P. Carbone, Marina Chiara Garassino, Fabrice Barlési

    Хэвлэсэн 2021
    Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  10. 10
    Guide to detecting epidermal growth factor receptor (<i>EGFR</i>) mutations in ctDNA of patients with advanced non-small-cell lung cancer

    Guide to detecting epidermal growth factor receptor (<i>EGFR</i>) mutations in ctDNA of patients with advanced non-small-cell lung cancer -н Nicola Normanno, Marc G. Denis, Kenneth S. Thress, M. Ratcliffe, Martin Reck

    Хэвлэсэн 2016
    Бүрэн текст авах Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  11. 11
    Anesthetic Influence on Occurrence and Treatment of the Trigemino-Cardiac Reflex

    Anesthetic Influence on Occurrence and Treatment of the Trigemino-Cardiac Reflex -н Cyrill Meuwly, Tumul Chowdhury, Nora Sandu, Martin Reck, Paul Erné, Bernhard Schaller

    Хэвлэсэн 2015
    Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  12. 12
    Epigenetic modifications of the immune-checkpoint genes CTLA4 and PDCD1 in non-small cell lung cancer results in increased expression

    Epigenetic modifications of the immune-checkpoint genes CTLA4 and PDCD1 in non-small cell lung cancer results in increased expression -н Sebastian Marwitz, Swetlana Scheufele, Sven Perner, Martin Reck, Ole Ammerpohl, Torsten Goldmann

    Хэвлэсэн 2017
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  13. 13
    Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up -н G. D’Addario, Martin Früh, Martin Reck, Pia Baumann, Walter Klepetko, Enriqueta Felip

    Хэвлэсэн 2010
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  14. 14
    Treatment Rationale and Study Design for the JUNIPER Study: A Randomized Phase III Study of Abemaciclib With Best Supportive Care Versus Erlotinib With Best Supportive Care in Patients With Stage IV Non–Small-Cell Lung Cancer With a Detectable KRAS Mutation Whose Disease Has Progressed After Platinum-Based Chemotherapy

    Treatment Rationale and Study Design for the JUNIPER Study: A Randomized Phase III Study of Abemaciclib With Best Supportive Care Versus Erlotinib With Best Supportive Care in Pati... -н Jonathan W. Goldman, Peipei Shi, Martin Reck, Luis Paz‐Ares, Andrew Koustenis, Karla Hurt

    Хэвлэсэн 2015
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  15. 15
    Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up -н Solange Peters, Alex A. Adjei, Cesare Gridelli, Martin Reck, K.M. Kerr, Enriqueta Felip

    Хэвлэсэн 2012
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  16. 16
    Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up -н Martin Reck, Sanjay Popat, Niels Reinmuth, Dirk De Ruysscher, Keith M. Kerr, Solange Peters

    Хэвлэсэн 2014
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  17. 17
    Efficacy and Safety of Bevacizumab-Based Therapy in Elderly Patients with Advanced or Recurrent Nonsquamous Non-small Cell Lung Cancer in the Phase III BO17704 Study (AVAiL)

    Efficacy and Safety of Bevacizumab-Based Therapy in Elderly Patients with Advanced or Recurrent Nonsquamous Non-small Cell Lung Cancer in the Phase III BO17704 Study (AVAiL) -н Natasha B. Leighl, Petr Zatloukal, J. Mezger, Rodryg Ramlau, N. Moore, Martin Reck, Christian Manegold

    Хэвлэсэн 2010
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  18. 18
    Small cell lung cancer: a slightly less orphan disease after immunotherapy

    Small cell lung cancer: a slightly less orphan disease after immunotherapy -н Jordi Remón, Mihaela Aldea, Benjamin Besse, David Planchard, Martin Reck, Giuseppe Giaccone, Jean‐Charles Soria

    Хэвлэсэн 2021
    Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  19. 19
    Predicting and managing the risk of pulmonary haemorrhage in patients with NSCLC treated with bevacizumab: a consensus report from a panel of experts

    Predicting and managing the risk of pulmonary haemorrhage in patients with NSCLC treated with bevacizumab: a consensus report from a panel of experts -н Martin Reck, Fabrice Barlési, Lucio Crinò, Claudia I. Henschke, Dolores Isla, Susanne Stiebeler, David R. Spigel

    Хэвлэсэн 2011
    Бүрэн текст авах Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  20. 20
    Anti-angiogenic agents in the age of resistance to immune checkpoint inhibitors: Do they have a role in non-oncogene-addicted non-small cell lung cancer?

    Anti-angiogenic agents in the age of resistance to immune checkpoint inhibitors: Do they have a role in non-oncogene-addicted non-small cell lung cancer? -н Sanjay Popat, Christian Grohé, J. Corral, Martin Reck, Silvia Novello, Maya Gottfried, Dejan Radonjic, R. Kaiser

    Хэвлэсэн 2020
    Бүрэн текст авах Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:

Хайх хэрэгслүүд: